Arcadia Biosciences, Inc. (RKDA) stock
RKDANasdaqBeveragesFiscal year ends December 31
$0.19−0.02 (-11.19%)
Close on Nov 16, 2026Market cap $466.42KP/E –Yield –
Arcadia Biosciences gross margin
Gross margin is gross profit as a percentage of revenue.
Arcadia Biosciences's gross margin for the twelve months ending Jun 30, 2026 was 34.6%. For fiscal 2025 it was 36.2%, against 41.3% the year before. The highest annual figure on record is 93.0% in fiscal 2017.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 36.2% | −5.0 |
| FY2024 | Dec 31, 2024 | 41.3% | −9.9 |
| FY2023 | Dec 31, 2023 | 51.2% | +33.4 |
| FY2022 | Dec 31, 2022 | 17.8% | +46.2 |
| FY2021 | Dec 31, 2021 | -28.4% | −63.7 |
| FY2020 | Dec 31, 2020 | 35.3% | −57.7 |
| FY2017 | Dec 31, 2017 | 93.0% | +21.0 |
| FY2016 | Dec 31, 2016 | 71.9% | −11.6 |
| FY2015 | Dec 31, 2015 | 83.5% | +12.1 |
| FY2014 | Dec 31, 2014 | 71.4% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 43.7% | +0.4 |
| Q1 FY2026 | Mar 31, 2026 | 36.4% | −6.8 |
| Q4 FY2025 | Dec 31, 2025 | 21.3% | −10.7 |
| Q3 FY2025 | Sep 30, 2025 | 32.1% | −0.8 |
| Q2 FY2025 | Jun 30, 2025 | 43.4% | −8.2 |
| Q1 FY2025 | Mar 31, 2025 | 43.2% | −9.1 |
| Q4 FY2024 | Dec 31, 2024 | 32.0% | −45.1 |
| Q3 FY2024 | Sep 30, 2024 | 32.9% | −4.1 |
| Q2 FY2024 | Jun 30, 2024 | 51.5% | +1.6 |
| Q1 FY2024 | Mar 31, 2024 | 52.3% | +8.1 |
| Q4 FY2023 | Dec 31, 2023 | 77.1% | +98.1 |
| Q3 FY2023 | Sep 30, 2023 | 37.0% | +8.8 |
| Q2 FY2023 | Jun 30, 2023 | 49.9% | +39.2 |
| Q1 FY2023 | Mar 31, 2023 | 44.2% | +51.5 |
| Q4 FY2022 | Dec 31, 2022 | -21.0% | +51.9 |
| Q3 FY2022 | Sep 30, 2022 | 28.2% | +33.8 |
| Q2 FY2022 | Jun 30, 2022 | 10.7% | +23.6 |
| Q1 FY2022 | Mar 31, 2022 | -7.4% | −4.0 |
| Q4 FY2021 | Dec 31, 2021 | -72.9% | −156.1 |
| Q3 FY2021 | Sep 30, 2021 | -5.7% | −104.2 |
| Q2 FY2021 | Jun 30, 2021 | -13.0% | −106.2 |
| Q1 FY2021 | Mar 31, 2021 | -3.4% | −91.7 |
| Q1 FY2018 | Mar 31, 2018 | 83.2% | −6.4 |
| Q4 FY2017 | Dec 31, 2017 | 98.5% | +119.5 |
| Q3 FY2017 | Sep 30, 2017 | 93.2% | −1.2 |
| Q2 FY2017 | Jun 30, 2017 | 88.3% | – |
| Q1 FY2017 | Mar 31, 2017 | 89.6% | – |
| Q4 FY2016 | Dec 31, 2016 | -20.9% | – |
| Q3 FY2016 | Sep 30, 2016 | 94.4% | – |
See a number that looks wrong?